5 sources checked · 2 source groups included · 4h ago
Still Watching
Astra Zeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
Fortune and The Straits Times describe the same event in different terms.
1 Left4 Center0 Right
Still watching.Optics is waiting for a cleaner match before calling the split.
STILL WATCHING
As of August 2, 2026 at 11:59 PM, this is how Optics News reads the wording differences in this story.
What happenedU.K. pharmaceutical giant Astra Zeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.
The headline splitThe left frames it as "Astra Zeneca said to have explored Bristol Myers merger". The center frames it as "Astra Zeneca holds talks with Bristol Myers Squibb on $512 billion megadeal: Report".
Match confidenceMedium confidence. 5 sources across 2 bias buckets. Useful framing signal — check the source list before sharing.
Same-event confidenceMedium
5 sources across 2 bias buckets agree on the event.
Framing confidenceModerate
56/99 — meaningful wording shift across the spectrum.
WHAT EACH SIDE EMPHASIZED
Left / center-leftAstra Zeneca said to have explored Bristol Myers merger
Fortune · Center-left · News report
CenterAstra Zeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
CNBC · Center · News report
Right / center-rightNo matching source in this bucket yet.
Astra Zeneca Is Said to Have Explored Bristol Myers Merger
Astra Zeneca Plc has explored an acquisition of Bristol Myers Squibb Co., a megadeal that would create one of the world’s largest drugmakers, according to people familiar with the matter.
